10 Tenet Healthcare Corp Analyst Ratings, Earnings, Dividends and Insider Trades | $THC | NYSE:THC | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Tenet Healthcare Corp Company Profile (NYSE:THC) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Tenet Healthcare Corp (NYSE:THC) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 10 Hold Rating(s), 11 Buy Rating(s)Consensus Rating:Buy (Score: 2.52)Consensus Price Target: $54.66 (27.64% upside) Analysts' Ratings History for Tenet Healthcare Corp (NYSE:THC) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014RBC CapitalLower Price Target$47.00 -> $43.00View 3/4/2014EVA DimensionsUpgradeUnderweight -> HoldView 3/3/2014BMO Capital MarketsReiterated RatingMarket Perform$47.00 -> $45.00View 2/26/2014ZacksReiterated RatingNeutral -> Neutral$46.00View 2/26/2014Credit SuisseCut EstimatesOutperformView 2/25/2014SusquehannaDowngradeNeutralView 2/25/2014CRT CapitalDowngradeBuy -> Fair Value$51.00 -> $41.50View 1/31/2014Leerink SwannBoost Price Target$107.00 -> $130.00View 1/8/2014Raymond JamesDowngradeOutperform -> Market Perform$50.00View 12/17/2013ZacksDowngradeNeutral -> Underperform$37.00View 11/21/2013Credit SuisseLower Price TargetOutperform$48.00View 11/19/2013ZacksUpgradeUnderperform -> Neutral$44.00View 11/13/2013MizuhoBoost Price TargetBuy$49.00 -> $52.00View 11/12/2013JPMorgan Chase & Co.Initiated CoverageOverweight$50.00View 11/8/2013FBR & Co.Initiated CoverageMarket PerformView 11/8/2013FBR Capital MarketsInitiated CoverageMarket Perform$49.00View 11/6/2013Wells Fargo & Co.DowngradeOutperform -> Market PerformView 11/5/2013Deutsche BankLower Price TargetBuy$65.00 -> $60.00View 10/15/2013BarclaysInitiated CoverageOverweight -> Overweight$55.00View 10/9/2013ZacksDowngradeNeutral -> Underperform$42.00View 10/8/2013Goldman SachsUpgradeNeutral -> Buy$47.00 -> $55.00View 10/7/2013Deutsche BankBoost Price TargetBuy$55.00 -> $65.00View 8/12/2013RBC CapitalLower Price TargetSector Perform$52.00 -> $47.00View 8/7/2013Raymond JamesLower Price Target$52.00 -> $50.00View 8/7/2013ZacksReiterated RatingNeutral -> Neutral$45.00View 8/7/2013UBS AGLower Price TargetBuy$55.00 -> $50.00View 7/11/2013ZacksReiterated RatingNeutral -> Neutral$45.00View 7/11/2013KeyCorpInitiated CoverageHoldView 7/4/2013RBC CapitalReiterated RatingSector Perform$52.00View 7/4/2013RBC CapitalReiterated RatingSector Perform$52.00View 6/25/2013BMO Capital MarketsReiterated RatingMarket Perform$48.00View 6/24/2013MizuhoReiterated RatingBuy$51.00View 6/6/2013Deutsche BankUpgradeHold -> Buy$49.00 -> $55.00View 6/3/2013CRT CapitalReiterated RatingBuy$51.00View 5/9/2013UBS AGBoost Price TargetBuy$50.00 -> $55.00View 5/6/2013MizuhoBoost Price TargetBuy$41.00 -> $51.00View 5/2/2013Credit SuisseBoost Price TargetOutperform$44.00 -> $52.00View 5/2/2013BMO Capital MarketsLower Price TargetMarket Perform$51.00 -> $48.00View 5/2/2013ZacksReiterated RatingNeutral -> Neutral$48.00View 5/1/2013BarclaysBoost Price TargetEqual Weight$41.00 -> $50.00View 4/30/2013S&P Equity ResearchUpgradeHold -> Buy$40.00 -> $49.00View 4/29/2013Jefferies GroupReiterated RatingBuy$48.00View 4/29/2013UBS AGUpgradeNeutral -> BuyView 4/29/2013Robert W. BairdUpgradeNeutral -> Outperform$44.00 -> $51.00View 4/23/2013Robert W. BairdBoost Price TargetNeutral -> Neutral$43.00 -> $44.00View 4/22/2013Deutsche BankReiterated RatingHold$46.00View 4/10/2013Deutsche BankDowngradeBuy -> Hold$46.00View 3/25/2013JPMorgan Chase & Co.Reiterated RatingOverweight$41.00 -> $55.00View 3/15/2013Ameriprise FinancialInitiated CoverageBuyView 3/14/2013ZacksDowngradeOutperform -> Neutral$46.00View 3/12/2013UBS AGBoost Price TargetNeutral$41.00 -> $46.00View 3/8/2013Deutsche BankReiterated RatingBuy$46.00 -> $46.00View 3/8/2013CRT CapitalUpgradeFair Value -> Buy$51.00View 3/7/2013RBC CapitalBoost Price TargetSector Perform$20.00 -> $38.00View 3/4/2013Jefferies GroupReiterated RatingBuy$26.00 -> $48.00View 3/4/2013JPMorgan Chase & Co.Reiterated RatingOverweight$41.00View 2/28/2013TheStreetUpgradeSell -> HoldView 2/27/2013Credit SuisseBoost Price Target$31.00 -> $44.00View 2/27/2013MizuhoBoost Price TargetBuy$40.00 -> $41.00View 2/27/2013BarclaysBoost Price TargetEqual Weight$36.00 -> $41.00View 2/27/2013BMO Capital MarketsReiterated RatingMarket Perform$38.00 -> $40.00View 2/12/2013Raymond JamesReiterated RatingOutperform$45.00View 1/30/2013Deutsche BankBoost Price TargetBuy$38.00 -> $43.00View 1/24/2013Raymond JamesUpgradeMarket Perform -> Outperform$45.00View 1/22/2013ZacksUpgradeNeutral -> Outperform$46.00View 1/18/2013MizuhoBoost Price TargetBuy$31.00 -> $40.00View 1/17/2013Morgan StanleyInitiated CoverageEqual WeightView 1/11/2013Bank of AmericaUpgradeNeutral -> Buy$32.00 -> $44.00View 1/4/2013BarclaysReiterated RatingEqual Weight$31.00 -> $36.00View 1/3/2013Imperial CapitalUpgradeIn -> line$20.00 -> $40.00View 12/18/2012JPMorgan Chase & Co.Initiated CoverageOverweight$41.00View 12/17/2012Deutsche BankUpgradeHold -> Buy$31.00 -> $38.00View 11/30/2012SusquehannaReiterated RatingNeutral$30.00View 11/26/2012Robert W. BairdLower Price TargetNeutral$29.00 -> $27.00View 11/12/2012UBS AGBoost Price TargetNeutral$26.00 -> $29.00View 11/8/2012ZacksReiterated RatingNeutral -> Neutral$29.00View 11/8/2012RBC CapitalReiterated RatingSector Perform$20.00View 11/7/2012Goldman SachsReiterated RatingNeutral$32.00View 10/19/2012ZacksDowngradeOutperform -> Neutral$25.00View 10/12/2012BarclaysReiterated RatingEqualweight$28.00View 10/11/2012BarclaysInitiated CoverageEqual Weight$7.00View 10/1/2012Bank of AmericaBoost Price Target$6.75View 9/28/2012Lazard Ltd.Reiterated RatingNeutralView 9/27/2012Deutsche BankReiterated RatingHold$6.50View 9/27/2012Dahlman RoseBoost Price TargetBuy$6.45 -> $7.65View 9/26/2012SunTrustInitiated CoverageNeutralView 9/25/2012UBS AGReiterated RatingNeutralView 9/19/2012Wells Fargo & Co.Reiterated RatingOutperformView 9/6/2012Imperial CapitalInitiated CoverageIn-line$5.00View 8/8/2012ZacksReiterated RatingOutperform -> Outperform$6.00View 7/27/2012ZacksUpgradeNeutral -> Outperform$5.25View 7/3/2012Raymond JamesDowngradeOutperform -> Market PerformView 6/29/2012Wells Fargo & Co.UpgradeMarket Perform -> OutperformView 6/20/2012UBS AGInitiated CoverageNeutral$5.00View 6/11/2012Citigroup Inc.UpgradeSell -> BuyView 5/29/2012CRT CapitalDowngradeBuy -> Fair ValueView 5/2/2012ZacksReiterated RatingNeutral -> Neutral$5.50View 3/16/2012Jefferies GroupBoost Price Target$6.50View (Data available from 3/8/2012 forward) Earnings History for Tenet Healthcare Corp (NYSE:THC)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/24/2014Q413$0.37$0.49$3.87 billion$3.89 billionViewN/AView 11/5/2013Q313$0.45$0.45$2.38 billion$2.62 billionViewListenView 8/6/2013Q2 2013$0.75($0.49)$2.46 billion$2.42 billionViewN/AView 4/30/2013Q1 2013$0.31$0.33$2.46 billion$2.59 billionViewListenView 2/26/2013Q4 2012$0.68$0.45$2.34 billion$2.33 billionViewListenView 11/7/2012Q312$0.32$0.34$2.42 billion$2.43 billionViewN/AView 8/7/2012$0.05$0.10ViewN/AView 5/8/2012$0.10$0.13ViewN/AView 2/28/2012$0.14$0.10ViewN/AView 11/1/2011$0.00$0.04ViewN/AView 8/2/2011$0.08$0.09ViewN/AView 5/3/2011$0.14$0.17ViewN/AView 2/25/2011$0.08$0.14ViewN/AView (Data available from 1/1/2011 forward) Dividend History for Tenet Healthcare Corp (NYSE:THC)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Tenet Healthcare Corp (NYSE:THC)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare12/23/2013Glenview Capital Management, Lmajor shareholderBuy248,910$39.79$9,904,128.90View 12/20/2013Glenview Capital Management, Lmajor shareholderBuy644,582$39.95$25,751,050.90View 12/18/2013Glenview Capital Management, Lmajor shareholderBuy1,000,000$40.12$40,120,000.00View 11/15/2013Keith PittsChairmanBuy6,250$43.13$269,562.50View 11/14/2013Keith PittsChairmanBuy6,250$43.14$269,625.00View 11/8/2013Keith PittsChairmanBuy7,500$41.85$313,875.00View 11/7/2013Keith PittsChairmanBuy5,000$41.97$209,850.00View 10/3/2013John Ellis BushDirectorSell16,582$45.10$747,848.20View 9/19/2013John Ellis BushDirectorSell8,291$42.90$355,683.90View 5/14/2013Glenview Capital Management, LMajor ShareholderSell4,000,000$47.75$191,000,000.00View 3/5/2013Edward A KangasChairmanSell7,000$39.88$279,160.00View 3/4/2013Trevor FetterCEOSell138,255$39.39$5,445,864.45View 10/19/2012Glenview Capital Management LlMajor ShareholderBuy200,000$23.53$4,706,000.00View 10/16/2012Glenview Capital Management LlMajor ShareholderBuy433,383$23.98$10,392,524.34View 9/17/2012Glenview Capital Management LlMajor ShareholderBuy750,000$5.75$4,312,500.00View (Data available from 1/1/2013 forward) About Tenet Healthcare Corp Tenet Healthcare Corporation (Tenet), along with its subsidiaries, is an investor-owned health care services company. Tenet operates 77 acute care hospitals, 173 outpatient centers, five health plans and six accountable care organizations. As of October 7, 2013, the Company's new hospital was under construction in New Braunfels, Texas. In addition, the Company includes Conifer Health Solutions, which provides health business process solutions at 15 service centers serving 600 clients across 43 states. The Company operates in two segments: hospital operations and other, and Conifer. In May 2012, the Company sold Diagnostic Imaging Services, Inc., its former diagnostic imaging center business in Louisiana. In August 2012, the Company sold its Creighton University Medical Center in Nebraska. In October 2013, Tenet Healthcare Corporation completed its acquisition of Vanguard Health Systems, Inc. Headlines: (2/25) Tenet Healthcare Beats on Q4 Earnings, Down Y/Y (2/26) Weakness Seen in Tenet Healthcare (THC): Stock Tumbles 9.1% (2/25) Tenet Declines as 2014 Forecast Fails to Meet Estimates (3/7) Tenet, Yale New Haven Collaborate (2/25) Tenet Healthcare Beats on Q4 Earnings, Down Y/Y - Analyst Blog (2/27) Tenet Arm, University Health Pen Deal (2/24) Tenet Healthcare Posts Loss (2/27) Tenet Arm, University Health Pen Deal - Analyst Blog Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Providers & Services Sub-Industry: Health Care Facilities Exchange: NYSE Symbol: THC CUSIP: 88033G40 Key Metrics: Previous Close: $42.8250 Day Moving Average: $45.2032200 Day Moving Average: $43.4073 P/E Ratio: N/AP/E Growth: 1.84Market Cap: $4.104BCurrent Quarter EPS Consensus Estimate: $1.35 EPS Additional Links: View THC on Google FinanceView THC on Yahoo FinanceView THC's Company Profile on ReutersSearch for Tenet Healthcare Corp on Google Tenet Healthcare Corp (NYSE:THC) Chart for Saturday, March, 8, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.